A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Bret Scholtes Biography and Net Worth

CEO of Guardion Health Sciences

Bret was appointed as President and Chief Executive Officer of Guardion Health Sciences in January of 2021. He is also a member of the company’s Board of Directors. Before joining Guardion, he spent nine years as the President and Chief Executive Officer of Omega Protein Corporation, and he was also a member of the company’s Board of Directors. Prior to becoming CEO, Bret served as Omega Protein’s Chief Financial Officer. Bret was also with General Electric for five years, has held strategy and corporate development positions at two publicly traded companies, and earned five years of public accounting experience at Arthur Andersen & Co. and Price Waterhouse.

What is Bret Scholtes' net worth?: The estimated net worth of Bret Scholtes is at least $27,797.21 as of August 30th, 2021. Mr. Scholtes owns 3,479 shares of Guardion Health Sciences stock worth more than $27,797 as of April 20th. This net worth approximation does not reflect any other investments that Mr. Scholtes may own. Learn More about Bret Scholtes' net worth.
How do I contact Bret Scholtes?: The corporate mailing address for Mr. Scholtes and other Guardion Health Sciences executives is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. Guardion Health Sciences can also be reached via phone at (800) 873-5141 and via email at [email protected]. Learn More on Bret Scholtes' contact information.
Has Bret Scholtes been buying or selling shares of Guardion Health Sciences?: Bret Scholtes has not been actively trading shares of Guardion Health Sciences over the course of the past ninety days. Most recently, on Monday, August 30th, Bret Scholtes bought 90 shares of Guardion Health Sciences stock. The stock was acquired at an average cost of $63.00 per share, with a total value of $5,670.00. Following the completion of the transaction, the chief executive officer now directly owns 3,479 shares of the company's stock, valued at $219,177. Learn More on Bret Scholtes' trading history.

Bret Scholtes Insider Trading History at Guardion Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/30/2021	Buy	90	$63.00	$5,670.00	3,479

Bret Scholtes Buying and Selling Activity at Guardion Health Sciences

Guardion Health Sciences Company Overview

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Today's Range

Now: $7.99

$7.80

$8.04

50 Day Range

MA: $8.42

$7.82

$9.10

2 Week Range

Now: $7.99

$5.01

$10.75

Volume

5,633 shs

Average Volume

182,059 shs

Market Capitalization

$10.23 million

P/E Ratio

72.64

Dividend Yield

N/A

Beta

0.88

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad